Angela V. Flannery

848 total citations · 1 hit paper
10 papers, 676 citations indexed

About

Angela V. Flannery is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Angela V. Flannery has authored 10 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Angela V. Flannery's work include Peptidase Inhibition and Analysis (5 papers), Protease and Inhibitor Mechanisms (4 papers) and Genetics and Neurodevelopmental Disorders (2 papers). Angela V. Flannery is often cited by papers focused on Peptidase Inhibition and Analysis (5 papers), Protease and Inhibitor Mechanisms (4 papers) and Genetics and Neurodevelopmental Disorders (2 papers). Angela V. Flannery collaborates with scholars based in United Kingdom, United States and Poland. Angela V. Flannery's co-authors include Tudor–Eliade Ciuleanu, Fred R. Hirsch, Nick Thatcher, Alex Y. Chang, José Rodrigues Pereira, Brian R. Holloway, Claire Watkins, Wilbur A. Franklin, Rafał Dziadziuszko and Joachim von Pawel and has published in prestigious journals such as Journal of Clinical Oncology, Human Molecular Genetics and Archives of Biochemistry and Biophysics.

In The Last Decade

Angela V. Flannery

10 papers receiving 661 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer

2006 570 citations Fred R. Hirsch, Marileila Varella‐Garcia et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angela V. Flannery United Kingdom	6	515	480	200	159	47	10	676
Maria S. Romero Spain	5	266 0.5×	297 0.6×	235 1.2×	56 0.4×	23 0.5×	6	497
Dan Chan United States	6	194 0.4×	287 0.6×	250 1.3×	84 0.5×	24 0.5×	13	532
Catherine B. Meador United States	11	338 0.7×	408 0.8×	352 1.8×	207 1.3×	26 0.6×	35	725
Ashutosh Lodhi United States	11	177 0.3×	613 1.3×	157 0.8×	454 2.9×	43 0.9×	19	744
Gabriela Raso United States	5	186 0.4×	243 0.5×	215 1.1×	104 0.7×	23 0.5×	6	532
Emily Burrows United States	6	350 0.7×	636 1.3×	204 1.0×	375 2.4×	34 0.7×	13	835
Jeffrey E. Lehr United States	7	120 0.2×	169 0.4×	308 1.5×	70 0.4×	50 1.1×	9	494
Alessio Schirone Italy	12	173 0.3×	242 0.5×	124 0.6×	144 0.9×	52 1.1×	22	432
Hannah F. Wingate United States	10	128 0.2×	326 0.7×	226 1.1×	95 0.6×	52 1.1×	15	467
Christopher Moy United States	12	177 0.3×	270 0.6×	363 1.8×	161 1.0×	18 0.4×	17	618

Countries citing papers authored by Angela V. Flannery

Since Specialization

Citations

This map shows the geographic impact of Angela V. Flannery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela V. Flannery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela V. Flannery more than expected).

Fields of papers citing papers by Angela V. Flannery

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela V. Flannery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela V. Flannery. The network helps show where Angela V. Flannery may publish in the future.

Co-authorship network of co-authors of Angela V. Flannery

This figure shows the co-authorship network connecting the top 25 collaborators of Angela V. Flannery. A scholar is included among the top collaborators of Angela V. Flannery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela V. Flannery. Angela V. Flannery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Hirsch, Fred R., Marileila Varella‐Garcia, Paul A. Bunn, et al.. (2006). Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 24(31). 5034–5042. 570 indexed citations breakdown →

2.

McLennan, Alexander G., Angela V. Flannery, John Morten, & Maaret Ridanpää. (1998). Chromosomal Localization of the Human Diadenosine 5′,5‴-P1,P4-Tetraphosphate Pyrophosphohydrolase (Ap4A Hydrolase) Gene (APAH1) to 9p13. Genomics. 47(2). 307–309. 2 indexed citations

3.

Jiang, Weiping & Angela V. Flannery. (1997). Correlation of the exon/intron organization to the secondary structures of the protease domain of mouse meprin α subunit. Gene. 189(1). 65–71. 7 indexed citations

4.

Chakrabarti, Lisa, Samantha J.L. Knight, Angela V. Flannery, & Kay E. Davies. (1996). A Candidate Gene for Mild Mental Handicap at the Fraxe Fragile Site. Human Molecular Genetics. 5(2). 275–282. 45 indexed citations

5.

Beynon, Robert J., Angela V. Flannery, Richard P. Evershed, et al.. (1996). Interrelationships between Metabolism of Glycogen Phosphorylase and Pyridoxal Phosphate—Implications in Mcardle's Disease. Advances in food and nutrition research. 40. 135–147. 1 indexed citations

6.

Flannery, Angela V., Mark C. Hirst, Samantha J.L. Knight, Rachael J. Ritchie, & Kay E. Davies. (1995). The fragile X syndrome. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1271(2-3). 293–303. 8 indexed citations

7.

Gorbea, Carlos, Angela V. Flannery, & Judith Bond. (1991). Homo- and heterotetrameric forms of the membrane-bound metalloendopeptidases meprin A and B. Archives of Biochemistry and Biophysics. 290(2). 549–553. 31 indexed citations

8.

Flannery, Angela V., et al.. (1991). Immunological characterisation of different meprin species in mice. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1079(1). 119–122. 4 indexed citations

9.

Flannery, Angela V., et al.. (1990). Proteolytic activity in mouse urine; relationship to the kidney metallo-endopeptidase, meprin. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1041(1). 64–70. 5 indexed citations

10.

Flannery, Angela V., et al.. (1990). Metallo-endopeptidase activity in mouse and rat urine. Biochemical Society Transactions. 18(5). 1023–1024. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact